InvestorsHub Logo
Followers 48
Posts 2740
Boards Moderated 0
Alias Born 02/06/2017

Re: georgebailey post# 684174

Tuesday, 04/09/2024 6:16:43 PM

Tuesday, April 09, 2024 6:16:43 PM

Post# of 689461
george

based on this and my own dumb ass 2 cents

https://www.cancer.gov/research/participate/clinical-trials/intervention/poly-iclc

do a search on dendritic cells

[color=red]

Flt3L, Radiation Therapy, Poly-ICLC, and Pembrolizumab in Treating Patients with Refractory Indolent Non-Hodgkin's Lymphoma, Metastatic Breast Cancer, or Head and Neck Cancer

A Vaccine (PGV001) in Combination with Immunotherapy (CDX-301 and Poly-ICLC) for the Treatment of Prostate Cancer

Neoantigen Vaccines Prior to Surgery for the Treatment of Patients with Pancreatic Cancer

Peptide-Pulsed Dendritic Cell Vaccination in Combination with Nivolumab and Ipilimumab for the Treatment of Recurrent and/or Progressive Diffuse Hemispheric Glioma, H3 G34-mutant

[/color]

So its beyond me to guess how the poly people see their future.

I assume they know that come hell or high water DCVax (both versions)
will employ poly as an off label.

You ask great questions but beyond my scope

regards
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News